$55.0M
The Oxford spinout secured backing from a group of healthcare investors to scale its EchoGo heart disease detection technology.
"Hospitals already possess the data; they just lack the tools to unlock its full diagnostic potential."
Blue Venture Fund
CorporateThe Blue Venture Fund is a healthcare focused investment collaboration backed by Blue Cross Blue Shield companies, the Blue Cross Blue Shield Association, and Sandbox, with over $890m committed across four funds.
Portfolio
1
companies
By category
- AI/ML£65.3M
By location
- Oxford£65.3M
Portfolio companies
Team
ES
Emir Sandhu
Managing Director
Recent investments
£23.7M
The Series B round was led by the Blue Venture Fund to accelerate the deployment of artificial intelligence in echocardiography.
"Echocardiograms uploaded to the cloud and analyzed by artificial intelligence are set to revolutionize cardiac disease treatment pathways by helping more people understand their risk of heart disease earlier and with greater accuracy,"
